SCHEMBL8375129

SCHEMBL8375129

CCN(CC)C(=O)O.Nc1ccncc1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 3/20 0.45
KDM6B O15054 3/20 0.45
KDM4C Q9H3R0 3/20 0.45
MEN1 O00255 2/20 0.45
MAPT P10636 2/20 0.45
KMT2A Q03164 2/20 0.45
KDM4A O75164 1/20 0.45
THRB P10828 1/20 0.45
KDM4D Q6B0I6 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
GLA P06280 1/20 0.44
GAA P10253 1/20 0.44
LMNA P02545 4/20 0.37
CYP2C9 P11712 3/20 0.37
CYP2C19 P33261 2/20 0.37
CHRM2 P08172 1/20 0.37
CHRM4 P08173 1/20 0.37
CHRM5 P08912 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylcarbate SCHEMBL8375856 0.83 KDM4C (0.50) KDM4EALDH1A1KDM6BKDM4CMEN1
SCHEMBL8375145 0.81 LMNA (0.44) KDM4EALDH1A1KDM6BKDM4CMEN1
SCHEMBL8375861 0.80 P2RX4 (0.39) KDM4EALDH1A1KDM6BKDM4CMEN1
SCHEMBL17438490 0.79 LMNA (0.47) KDM4EALDH1A1KDM6BKDM4CMEN1
SCHEMBL8376698 0.78 KDM4C (0.43) KDM4EALDH1A1KDM6BKDM4CMEN1
SCHEMBL17438787 0.78 LMNA (0.46) KDM4EALDH1A1KDM6BKDM4CMEN1
SCHEMBL218758 0.77
SCHEMBL30015578 0.77
SCHEMBL8376711 0.77 HSD17B10 (0.42) KDM4EALDH1A1KDM6BKDM4CMAPT
Trifluoroacetic Acid SCHEMBL8375149 0.76 L3MBTL1 (0.42) KDM4EALDH1A1KDM6BKDM4CMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US claimed
US-5869480-A ALLEVIATING MEMORY DYSFUNCTION CHARACTERIZED BY CHOLINERGIC DEFICIT HOECHST MARION ROUSSEL INC. (US) 1999-02-09 US disclosed
US-5866565-A ALZHEIMER'S DISORDERS HOECHST MARION ROUSSEL INC. (US) 1999-02-02 US disclosed
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US disclosed
EP-0477903-B1 Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments HOECHST ROUSSEL PHARMA (US) 1996-04-03 EP disclosed
EP-0477903-A2 Substituted-4-amino-3-pyridinols, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1992-04-01 EP disclosed